Banque Pictet & Cie Sa Kymera Therapeutics, Inc. Transaction History

Banque Pictet & Cie Sa

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$20.91 - $34.27 $1,965 - $3,221	-94 Reduced 0.37%	25,031 $545 Million
Q2 2022 Aug 08, 2022	SELL	$14.13 - $42.55 $34,166 - $102,885	-2,418 Reduced 8.78%	25,125 $495,000
Q1 2022 May 04, 2022	BUY	$35.3 - $64.68 $972,267 - $1.78 Million	27,543 New	27,543 $1.17 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.